BI 655130

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for BI 655130, covering 2019-11-26 to 2024-07-03. Get the full timeline:

Most recent: Clinical Trial Update: BI 655130 Long-term Treatment in Patients With moderate-to Severe Ulcerative Colitis [Phase 2]